Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization ...lebanon

THE DAILY STAR - News
Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization
Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization )

Also on site :